| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of 1 Neuroscience and 2 Ophthalmology, University of California School of Medicine, San Diego, California; and 3 Departments of Anesthesiology, and Physiology and Biophysics, University of Washington, Seattle, Washington.
Abstract
PURPOSE. To determine the presence and distribution of CB1 cannabinoid receptors within the human eye.
METHODS. A subtype-specific affinity-purified polyclonal antibody to the cannabinoid CB1 receptor was used to determine CB1 localization. Postmortem human eyes were fixed in methacarn and embedded in paraffin. Sagittal sections were mounted on slides and immunostained using antibodies to the CB1 receptor. Antibody binding was detected either by using peroxidase conjugated secondary antibodies and developing with diaminobenzidine or by using fluorescent secondary antibodies.
RESULTS. Strong CB1 receptor labeling was detected in the ciliary epithelium, the corneal epithelium, and endothelium of the anterior human eye. Strong-to-moderate levels of CB1 staining were found in the trabecular meshwork and Schlemm’s canal. Moderate labeling was detected in the ciliary muscle and in the blood vessels of the ciliary body. Moderate-to-light labeling also was detected in the sphincter papillae of the anterior human eye. Staining for CB1 receptors also was detected in human retina. The two synaptic layers of the retina and the inner and outer plexiform layers, were both moderately stained for CB1. In addition, moderate labeling was detected in the inner nuclear layer, and the ganglion cell layer. Strong labeling was detected in the outer segments of photoreceptors. No staining was observed in the corneal stroma or in the choroid.
CONCLUSIONS. The wide distribution of cannabinoid CB1 receptors in both the anterior eye and the retina of humans suggests that cannabinoids influence several different physiological functions in the human eye.
This article has been cited by other articles:
|
|
 |
|
  Y. F. Njie, Z. Qiao, Z. Xiao, W. Wang, and Z.-H. Song N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4528 - 4534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zuurman, C. Roy, R. Schoemaker, A. Hazekamp, J. den Hartigh, J. Bender, R. Verpoorte, J. Pinquier, A. Cohen, and J. van Gerven Effect of intrapulmonary tetrahydrocannabinol administration in humans J Psychopharmacol, September 1, 2008; 22(7): 707 - 716. [Abstract] [PDF]
|
|
|
|
 |
|
 A.H. Taylor, C. Ang, S.C. Bell, and J.C. Konje The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy Hum. Reprod. Update, September 1, 2007; 13(5): 501 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Romano and M. D. Lograno Evidence for the Involvement of Cannabinoid CB1 Receptors in the Bimatoprost-Induced Contractions on the Human Isolated Ciliary Muscle Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3677 - 3682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. F. Njie, A. Kumar, Z. Qiao, L. Zhong, and Z.-H. Song Noladin Ether Acts on Trabecular Meshwork Cannabinoid (CB1) Receptors to Enhance Aqueous Humor Outflow Facility Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1999 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhong, L. Geng, Y. Njie, W. Feng, and Z.-H. Song CB2 Cannabinoid Receptors in Trabecular Meshwork Cells Mediate JWH015-Induced Enhancement of Aqueous Humor Outflow Facility Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1988 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Tomida, R G Pertwee, and A Azuara-Blanco Cannabinoids and glaucoma Br J Ophthalmol, May 1, 2004; 88(5): 708 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Straiker and J. M. Sullivan Cannabinoid Receptor Activation Differentially Modulates Ion Channels in Photoreceptors of the Tiger Salamander J Neurophysiol, May 1, 2003; 89(5): 2647 - 2654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Y. Chien, R.-F. Wang, T. W. Mittag, and S. M. Podos Effect of WIN 55212-2, a Cannabinoid Receptor Agonist, on Aqueous Humor Dynamics in Monkeys Arch Ophthalmol, January 1, 2003; 121(1): 87 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Laine, K. Jarvinen, D. W. Pate, A. Urtti, and T. Jarvinen Effect of the Enzyme Inhibitor, Phenylmethylsulfonyl Fluoride, on the IOP Profiles of Topical Anandamides Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 393 - 397. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
